#VisualAbstract Aflibercept Biosimilar MYL-1701P vs. Aflibercept in Diabetic Macular Edema
Click here to read this study in JAMA Ophthalmology. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Tag: diabetic macular edema
High dose aflibercept reduced treatment burden in patients with diabetic macular edema
1. Aflibercept 8 mg was non-inferior to 2 mg for best-corrected visual acuity at 48 weeks. 2. Ocular adverse events ...
Aflibercept monotherapy equivalent to bevacizumab first for diabetic macular edema
1. In patients with diabetic macular edema, aflibercept monotherapy showed no difference in vision improvement compared to step therapy of ...
Subthreshold micropulse laser is equivalent to standard laser for treating diabetic macular edema
1. In a randomized trial of about 250 patients with mild or moderate center-involving diabetic macula edema (DME), subthreshold micropulse ...
Faricimab may improve visual acuity in patients with diabetic macular edema
1. Faricimab every 8 weeks and faricimab per personalized treatment interval (PTI) were noninferior to aflibercept for mean change in ...
No increased overall risk of systemic events with use of anti-VEGF eye treatments
1. There was no overall increase in systemic cardiovascular events with the use of antibodies to vascular endothelial growth factor ...
Steroid implant may improve diabetic macular edema
1. Both the 0.35mg and 0.7mg dexamethasone dosing led to a significant increase in visual acuity compared to sham. 2. ...
Diabetic patients report improved vision after ranibizumab treatment
Image: PD Diabetic Macular Edema 1. Mean patient-reported visual improvement scores increased with ranibizumab monotherapy and ranibizumab + laser with ...